• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Stereotactic body radiation therapy in patients with hepatocellular carcinoma:A mini-review

    2019-06-11 07:30:18SabineGerumAlexandraJensenFalkRoeder

    Sabine Gerum, Alexandra D Jensen, Falk Roeder

    Sabine Gerum, Department of Radiation Oncology, University Hospital LMU Munich,Munich, 81377, Germany

    Alexandra D Jensen, Department of Radiation Oncology, University Hospital Gie?en and Marburg, Marburg, 35043, Germany

    Falk Roeder, CCU Molecular Radiation Oncology, German Cancer Research Center,Heidelberg, 74626, Germany

    Falk Roeder, Department of Radiotherapy and Radiation Oncology, Paracelsus Medical University, Salzburg, 5020, Austria

    Abstract

    Key words:Hepatocellular carcinoma; Stereotactic body radiation therapy; Local-ablative treatment; Combination approaches; Mini-review

    INTRODUCTION

    Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and ranking as the third most common cause of cancer death[1]. Tumour resection or liver transplantation is the main curative treatment options. However, only a minority of patients are suitable candidates for surgical treatment due to major vascular involvement, large multifocal lesions or accompanying comorbidities such as poor liver function or associated problems[2]. In the past, inoperable cases have traditionally been regarded as incurable. Treatment paradigms have changed dramatically in favor of local treatments in the last decades though. Even in inoperable patients, there is now emerging evidence of survival benefit or potential cure in inoperable patients receiving local treatments[3,4]. In consequence, local therapies should be considered in patients not eligible for curative surgery, or as a part of a strategy to bridge patients awaiting liver transplantation according to common guidelines[5]. Local treatments are broadly classified into two categories:Arterially-directed and locally ablative therapies. Arterially directed therapies include transarterial chemoembolization(TACE), transarterial chemoembolisation with drug eluting beds (DEB-TACE), and selective internal radiotherapy (SIRT). Locally ablative techniques include radiofrequency ablation (RFA), percutaneous alcohol injection, microwave or (less invasive) Stereotactic body radiation therapy (SBRT). However, potential benefits of these treatments need to be weighed against the potential treatment-induced impairment of liver function or even liver failure especially in the presence of underlying liver disease as a primary cause of most primary hepatic malignancies[4].All of these treatments also have limitations and appropriate patient selection is crucial to achieve positive outcomes:Patients with multiple comorbidities or inadequate liver function are usually poor candidates for surgical inverventions[4],patients with lesions directly adjacent to major vessels or bile ducts are not well suited for RFA[6], and patients with portal vein thrombosis rarely qualify for TACE or SIRT[7].

    SBRT is an additional locally ablative treatment option for patients with HCC who are not eligible for resection or other local treatments. It can also be used to bridge waiting time in patients qualifying for transplantation or as part of multi-modality treatments with other liver- directed therapies[3]. In the absence of level I evidence,SBRT is not considered a standard in many guidelines, unfortunately. This minireview describes current SBRT techniques and summarizes published evidence regarding efficacy and toxicity as a single treatment or in combination with other liver-directed therapies.

    SBRT: INDICATIONS AND TECHNIQUES

    SBRT is a highly conformal technique of external beam radiation therapy (EBRT)delivering high radiation doses in a small number of fractions[8]. Tumour control is achieved by high doses per fraction leading to high biological effectiveness and hence increased cell kill. Due to sharp dose gradients outside the target volume, dose to adjacent organs at risk is effectively limited maintaining adequate organ function.Stereotactic radiotherapy was initially developed for treatment of small cerebral lesions as stereotactic radiosurgery (SRS), the same principle was developed further in order to treat extracranial lesions (SBRT = stereotactic body radiation therapy). SRS and SBRT have now been widely accepted as standard of care for the treatment of limited brain or lung metastases as well as for early stage non-small-cell lung cancer.Clinical studies could show that SRS/SBRT and surgical approaches yield comparable results[8-10]. Meanwhile, SBRT is increasingly used for treatment of liver, lymph node or bony lesions[4,11,12].

    In liver lesions, SBRT is usually indicated in patients with 1-3 lesions with a maximum diameter of 5-6 cm[13]who are not eligible for resection or other local therapies either as definitive or bridging therapy prior to transplantation[13].Preservation of adequate liver function is mandatory, which is estimated individually based on total liver volume, lesion size and number, prior treatments and current liver function[4,13]. In general, patients with liver cirrhosis Child Pugh class A and early B are suitable candidates. In contrast to RFA/TACE treatment, patients with lesions located close to the liver surface, directly adjacent to large vessels, or portal vein thrombosis as well as patients presenting with extensive ascites are still candidates for SBRT. In contrast, However, patients with lesions directly adjacent to structures with low radiation tolerance like small bowel or stomach are less good candidates because dose reduction may be necessary[4,14,15].

    Technically, SBRT is a form of precision external beam radiation therapy using minimal safety margins[8]. In consequence, accurate target delineation and treatment planning, precise patient positioning, careful image guidance and adequate motion management strategies are mandatory. Target delineation usually includes multimodality imaging such as multi-phase contrast-enhanced computed tomography (CT)and magnetic resonance imaging preferably with liver-specific contrast-agents (see Figure 1). Patient positioning may include supportive vacuum pillows or other immobilization devices. Treatment planning is usually performed using multi-field or rotational techniques (see Figure 2). On-board imaging usually includes at least threedimensional cone beam CT prior to each fraction. Unfortunately, HCCs are poorly visible in native CT scans and can therefore rarely be identified by linac-based imaging, hence perilesional placement of fiducials prior to treatment planning is commonly necessary[4,16,17]. Depending on respective SBRT strategy, 1-4 gold or platin markers are placed near the lesion under CT or ultrasound guidance. These markers can be easily identified with all common image-guidance procedures (especially cone beam-CT) and used for patient set-up as well as gating or tracking strategies[4].Exceptions can be made if SBRT is applied shortly following TACE and there is still adequate contrast enhancement of lipiodol or if clips from prior surgical resections are present in direct proximity to the current lesions[3,4], (see Figure 2).

    Apart from implantation of fiducial markers, SBRT represents a non-invasive treatment option. Motion mitigation may be managed by either internal target volume concepts (ITV) or gating/tracking strategies. In order to define the ITV, the lesion is delineated on different respiratory phases based on a contrast-enhanced fourdimensional CT. The ITV corresponds to the resulting enveloping volume, which includes each delineated lesion position during the respiratory cycle and can be treated without breathing control or gating. In patients with large respiratory excursions, abdominal compression devices may be used to reduce motion and therefore limit resulting absolute ITVs[18]. In gating strategies, lesion motion is either derived from continuous breathing detection by imaging or patient surface detection or continuously detected through electromagnetic transponders. Radiation is applied only during short phases of the breathing cycle when the specific lesion is within a specified position or corridor, tracking techniques model lesion motion with respect to the breathing cycle. Accuracy of the model is checked and corrected in real time feeding back to the treatment position. In consequence, the radiation beam moves with the target and according to the model utilizing the whole breathing cycle and thereby reducing overall treatment time as compared to gating strategies. Doses are typically prescribed to a lesion-surrounding isodose (i.e., 65% or 80%), resulting in inhomogenous dose distributions. The lesion center therefore intentionally receives significantly higher doses while doses fall off quite sharply outside of the target volume. In consequence, doses and toxicities in adjacent normal tissue are reduced(see Figure 2). A variety of dose prescription and fractionation schedules have been employed. Currently most centers use 3-6 fractions of 8-20 Gy each, depending on localization, lesion size and liver function[4]. In order to preserve adequate liver function following SBRT, attention needs to be paid to specifying and sparing a threshold volume of uninvolved liver (usually 700 mL). In addition, excessive doses to luminal structures must be avoided by keeping a minimum distance (i.e., 5mm) to the high-dose area within the lesion[4]. If adequately performed, acute side effects following SBRT are rare and generally mild. These include fatigue, transient elevation of liver enzymes or unspecific abdominal symptoms. Late toxicities may include radiation-induced liver disease resulting in impaired liver function, gastrointestinal side effects like ulceration or stenosis, biliary complications and rib fractures.However, high-grade toxicities were rare and usually lower than in comparable series using alternative locally-ablative techniques[19-21]. Close follow-up evaluations including repeated imaging (see Figure 3) are necessary in order to evaluate resultant toxicity and to detect early local or distant progression[3]. It is of note though that SBRT may induce several and characteristic types of tumor and surrounding tissuealterations over time which should not be confused with progressive disease. For example, Herfarthet al[22]described three distinct types of focal reactions on multiphase contrast-enhanced CT following SBRT in their landmark paper. All of those are subject to substantial change over time and correlated to applied dose but have to be distinguished from disease recurrence. Lesions treated by SBRT may show signs of activity like hypervascularisation, wash-out or absence of regression in size up to 12 mo after treatment without residual viable tumor as reported by Mendiratta-Lalaet al[23]. Tétreauet al[24]compared different criteria for response evaluation and found that RECIST (Response evaluation criteria in solid tumors) criteria were unsuitable for response assessment and were outperformed by EASL (European Association of Study of the liver) criteria at each point of time during available followup. Therefore, response assessment including decision-making for salvage treatments following SBRT should preferably be made by a multidisciplinary panel including experienced radiation oncologists.

    Figure 1 Hepatocellular carcinoma in segment Vlll at diagnosis.

    SBRT: CLINICAL EVIDENCE

    In recent years an increasing number studies have been published, including mainly small retrospective cohorts but also larger series and well-designed phase II trials, see Table 1. Comparison of published data is hampered by varying and inhomogenous inclusion criteria across these studies. In addition, most series include large numbers of patients/lesions receiving SBRT because they were not eligible for other local treatments options (anymore) and/or have been treated with other techniques multiple times before. In consequence, most SBRT series represent a negative preselection of patients ex ante as compared to series reporting on other local treatments mainly as the primary treatment option. Nevertheless, SBRT resulted in very encouraging local control (1-year LC 65%-100%) and overall survival rates (1-year OS 32%-94%) with low toxicity[14,25-39]. In addition to dose and fractionation[28,30,34], local control appears to be determined by lesion size[28,34]and number of lesions[1], while overall survival is strongly associated with general condition and liver function prior to treatment. Several groups have consistently shown clear survival benefits after SBRT in Child-Pugh class A (CP-A) patients when compared to CP-B patients[14,27,34,39].CP-B patients further suffered from significantly increased toxicity despite receiving lower SBRT doses and less aggressive fractionation schemes[14,27], thus possible benefits and risks of SBRT have to be considered carefully when selecting those patients for treatment.

    Direct comparisons of SBRT with other local treatment options are limited and analyses most commonly retrospective (see Table 2). Suet al[40]compared SBRT with surgery in a propensity score matched cohort. Only patients with adequate liver function (CP-A), relatively small lesions (median 3.3 cm) treated in primary situation were included in the analysis. Despite mature follow-up of these cohorts, the authors could not detect significant differences between these treatment modalities with regard to either local control or overall survival. However, they described significant differences in accompanying toxicity profiles. While surgically treated patients showed less nausea, SBRT patients suffered less often from bleeding and pain. Wahlet al[19]performed a retrospective comparison of SBRT and RFA in a series of 224 patients. Except for a distinctly higher rate of prior treatments in the SBRT group,both arms seemed comparable with respect to major prognostic factors. Again, nosignificant difference in local control and overall survival was found between the cohorts. While both treatment were similarly efficient in lesions < 2 cm, the analysis showed significantly improved local control in patients treated with SBRT for larger lesions[19]. Sapiret al[20]compared SBRT with TACE in a retrospective series including 209 patients. Both groups were comparable with respect to their baseline characteristics with two exceptions:patients in the SBRT group were more heavily pre-treated, while mean lesion diameter was higher in the TACE group. Keeping those limitations in mind, SBRT resulted in significantly increased local control (1-year LC 97%vs47%) and favourable toxicity profile although this benefit did not translate into a clear survival benefit (1-year OS 75%vs74%)[20].

    Figure 2 Treatment plan (prescription dose 3 × 12.5 Gy to 65% surrounding isodose).

    In summary, SBRT seems to result at least in similar local control and overall survival rates as compared to other local treatments while showing mainly favorable toxicity profiles based on currently available albeit limited evidence. Therefore, SBRT may represent a reasonable alternative to other local treatments and should be considered as potential treatment modality in multidisciplinary evaluations of suitable patients.

    SBRT COMBINED WITH OTHER TREATMENTS

    RFA/TACE

    Combination of SBRT with other local therapies for treatment of either the same or different lesions may result in synergistic effects[3]. In case of multifocal disease with several lesions of various sites and size, some lesions may be easily addressed by RFA while others (i.e., due to close proximity to major vessels) may profit from SBRT.When combining different approaches, invasive procedures should be scheduled first,as fiducials (which are often necessary for SBRT) can be implanted in the same session without risks of an additional intervention.

    Figure 3 Complete response 9 months after transarterial chemoembolization and stereotactic body radiation therapy.

    Combining TACE with SBRT in the treatment of the same lesion may offer several advantages (see Figure 1-3). Prior TACE may result in tumour response and hence smaller SBRT volume leading to potentially improved toxicity[4]. Chemotherapy as a component of TACE may act as a radiosensitizer also enhancing the radiation effect of SBRT[4], although this might be counterbalanced by tumor hypoxia induced by embolization. Lipiodol deposits placed during embolization can also serve as landmarks for image guidance in SBRT, which may potentially render fiducial placement unnecessary[3,4]. Indeed, small retrospective series have shown significant improvements regarding treatment response, local control, progression-free survival,and even overall survival by the addition of SBRT to TACE compared to TACE alone at least if lesion size exceeded 3 cm[41,42]. Kanget al[28]reported a prospective phase II trial using SBRT following TACE. Fifty patients with lesion size < 10 cm and CP-A or early CP-B cirrhosis were enrolled. Patients received SBRT in 3 fractions with 14-20 Gy per fraction. The group reported very encouraging 2-year local and overall survival rates of 95% and 69%. Toxicities of grade III or higher were observed in only 10% despite comparatively high doses. In summary, combination of TACE and SBRT seems to be a very promising approach, which is currently evaluated in several prospective trials.

    Sorafenib

    Although preclinical data suggested radiation-sensitizing effects of sorafenib[43],combination of Sorafenib with SBRT does not appear advisable. Prospective clinical trials reported discouraging toxicities:Bradeet al[44]conducted a phase I trial investigating SBRT with concurrent Sorafenib in CP-A patients unsuitable for standard local therapies. Nine out of 16 patients showed grade 3+ toxicity including 2 deaths. While 15 of 16 patients completed SBRT as planned, adherence to Sorafenib treatment was poor:Only 3 out of 16 patients completed treatment for the first 12 wk without modifications. The authors concluded that concurrent use of SBRT and Sorafenib should not be recommended. Based on the preclinical data they advocated in favor of evaluating a sequential approach, which is currently under investigation within a randomized trial (RTOG 112).

    SBRT AS BRIDGING TO TRANSPLANT

    Many patients who were initially eligible for liver transplantation unfortunately drop off waiting lists due to tumour progression. As a result, increasing attention is paid to bridging approaches to reduce this number. Based on limited evidence from retrospective analyses, SBRT seems to be a reasonable option. For example, Katzet al[45]reported 18 patients treated with SBRT as bridging approach. All patients received 50 Gy in 10 fractions. 6 patients were delisted due to various reasons while the remaining 12 finally received major surgery or transplant after a median of 6.3 months. No grade 3+ toxicities were reported. Pathologic complete response rate in explanted organs following SBRT was 20%. Local control until transplantation was achieved in all patients. With a median follow-up of 20 mo, all patients are diseasefree and alive. O′Connoret al[46]similarly described a series of 11 patients with median lesion size of 3.4 cm who received SBRT with 33-54 Gy in 3 fractions as bridging.Patients underwent liver transplantation after a median interval of 113 d. Again no patient experienced grade 3+ toxicity. Pathologic complete response was found in 27% and 5-year DFS and OS after transplantation were 100%. Interestingly, patients receiving 54 Gy in 3 fractions showed a distinctly higher pathologic complete response rate of 60%. Mohamedet al[21]evaluated various bridging strategies including RFA, TACE, SBRT and SIRT. They found high pathologic complete response rates for all bridging treatments but noticed favorable toxicity profiles for SBRT and SIRT (no grade 3+ toxicity). Finally, Murrayet al[4]noted in a recent reviewthat 63%-100% of patients treated with SBRT as bridging proceeded to transplantation with explants showing pathologic complete and partial responses in 14%-27% and 23%-64% of lesions.

    Table 1 Prospective trials and large ( > 100 patients) retrospective series evaluating stereotactic body radiation therapy in hepatocellular carcinoma

    In summary, SBRT seems to be another suitable option to bridge patients scheduled for liver transplant, which shows similar response rates but very modest toxicity profiles as compared to other local treatment options and should be considered in the multidisciplinary evaluation.

    FUTURE DIRECTIONS

    Future developments regarding SBRT mainly focus on MRI-based treatment planning followed by real-time MRI-guided radiation therapy. The implementation of daily image guidance and replanning using MR-linac technology with enhanced soft-tissue information may not only result in increased set-up accuracy. It may however, allow omission of fiducial placement prior to SBRT, thus rendering SBRT a completely noninvasive treatment option. Furthermore, particle therapy (protons or heavy ions)seems to be a promising option due to higher biological effectiveness (heavy ions) and dosimetric advantages. However, the main benefit of protons (the lack of exit dose)may be offset in liver tumors by several factors:Meticulous motion mitigation techniques are crucial in order to minimize range uncertainties caused by moving airsoft-tissue or air-bony interface. Air-filled cavities in adjacent luminal organs presentfurther challenges[47]. Nevertheless, several reports describing early experiences with protons have shown high local control rates and low toxicities[48,49]. The potential benefit is currently evaluated in a phase III trial (NRG-GI003) comparing photon and proton SBRT in unresectable HCC[47].

    Table 2 Studies comparing stereotactic body radiation therapy to other local treatments

    CONCLUSIONS

    Evidence comparing various strategies for the treatment of HCC is limited. Based on available data, SBRT is an effective treatment option for HCC accompanied by low rates of toxicity. Outcomes seem at least comparable to other local treatment options or limited (non-transplantation) surgical approaches. Combination with other local therapies especially TACE appears to be feasible and seems to result in synergistic effects. SBRT may also be reasonably used as a bridging option in patients awaiting liver transplantation. Dose and fractionation should be prescribed individually based on liver volume, lesion size and number, prior treatments, current liver function and adjacent organs at risk and adequate patient selection is crucial.

    国产av一区在线观看免费| 免费av不卡在线播放| 欧美最新免费一区二区三区| 亚洲成人中文字幕在线播放| 日韩强制内射视频| 可以在线观看的亚洲视频| 午夜久久久久精精品| 午夜免费男女啪啪视频观看| av在线蜜桃| 丰满的人妻完整版| 亚洲欧美日韩卡通动漫| 国产v大片淫在线免费观看| 午夜视频国产福利| 国产免费一级a男人的天堂| 男女做爰动态图高潮gif福利片| 亚洲最大成人av| 男人和女人高潮做爰伦理| 亚洲美女搞黄在线观看| 白带黄色成豆腐渣| 国产真实伦视频高清在线观看| 国产一区二区激情短视频| videossex国产| 如何舔出高潮| 国内精品一区二区在线观看| 在线观看一区二区三区| 免费搜索国产男女视频| 国产精品久久电影中文字幕| 色综合色国产| 国产午夜精品久久久久久一区二区三区| 有码 亚洲区| 能在线免费看毛片的网站| 免费看av在线观看网站| 日日摸夜夜添夜夜添av毛片| 最好的美女福利视频网| 偷拍熟女少妇极品色| 最近2019中文字幕mv第一页| 午夜免费男女啪啪视频观看| 黄片无遮挡物在线观看| 国产不卡一卡二| 18禁在线播放成人免费| 女人被狂操c到高潮| 亚洲人成网站在线观看播放| 99国产极品粉嫩在线观看| 中文精品一卡2卡3卡4更新| 午夜老司机福利剧场| 午夜福利成人在线免费观看| 精品少妇黑人巨大在线播放 | 99国产极品粉嫩在线观看| 亚洲欧洲日产国产| 非洲黑人性xxxx精品又粗又长| 看片在线看免费视频| 我的老师免费观看完整版| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 99热这里只有是精品50| 色哟哟哟哟哟哟| 在线免费观看的www视频| 精品久久久久久久末码| 日韩欧美国产在线观看| 欧美日韩一区二区视频在线观看视频在线 | 国产高清视频在线观看网站| 春色校园在线视频观看| 国产淫片久久久久久久久| 久久久久久久亚洲中文字幕| 边亲边吃奶的免费视频| 91久久精品国产一区二区三区| 国产精品久久久久久精品电影小说 | 午夜免费男女啪啪视频观看| 少妇人妻一区二区三区视频| 色播亚洲综合网| 国产精品蜜桃在线观看 | 久久久久久久午夜电影| 桃色一区二区三区在线观看| 国内精品一区二区在线观看| 亚洲av.av天堂| 午夜免费激情av| 中文在线观看免费www的网站| .国产精品久久| 久久99热这里只有精品18| 国产成人a∨麻豆精品| 一卡2卡三卡四卡精品乱码亚洲| 久久精品国产亚洲av涩爱 | 中文在线观看免费www的网站| 九九在线视频观看精品| 男女边吃奶边做爰视频| 国产麻豆成人av免费视频| 久久久欧美国产精品| 亚洲精品亚洲一区二区| 一个人免费在线观看电影| 免费看av在线观看网站| 波野结衣二区三区在线| 亚州av有码| 久久九九热精品免费| 青春草视频在线免费观看| 成人毛片60女人毛片免费| 欧美精品国产亚洲| 欧美色视频一区免费| 啦啦啦观看免费观看视频高清| 寂寞人妻少妇视频99o| 国产高清视频在线观看网站| 熟女人妻精品中文字幕| 久久久久免费精品人妻一区二区| 91av网一区二区| 日韩av在线大香蕉| 真实男女啪啪啪动态图| 国产乱人视频| 精品免费久久久久久久清纯| av黄色大香蕉| ponron亚洲| 久久久精品欧美日韩精品| 女人被狂操c到高潮| 国产毛片a区久久久久| 搡女人真爽免费视频火全软件| 男女边吃奶边做爰视频| 中文字幕精品亚洲无线码一区| 人人妻人人看人人澡| 只有这里有精品99| 女人十人毛片免费观看3o分钟| 精品99又大又爽又粗少妇毛片| 国产黄片美女视频| 亚洲18禁久久av| 国产片特级美女逼逼视频| 亚洲av中文字字幕乱码综合| 看非洲黑人一级黄片| 中国美女看黄片| 老女人水多毛片| 亚洲一区二区三区色噜噜| 亚洲精品粉嫩美女一区| 久久99热6这里只有精品| 黄色配什么色好看| 国产成年人精品一区二区| 亚洲四区av| 国产精品电影一区二区三区| 亚洲国产精品sss在线观看| 女人十人毛片免费观看3o分钟| 又爽又黄a免费视频| 亚洲第一区二区三区不卡| 变态另类丝袜制服| 亚洲精品456在线播放app| 国产精品.久久久| 美女国产视频在线观看| 亚洲人与动物交配视频| 黄色日韩在线| 久久精品综合一区二区三区| 一卡2卡三卡四卡精品乱码亚洲| 九九在线视频观看精品| 美女xxoo啪啪120秒动态图| 欧美极品一区二区三区四区| 我的老师免费观看完整版| 亚洲精品国产成人久久av| 国产69精品久久久久777片| www.av在线官网国产| 亚洲一级一片aⅴ在线观看| 亚洲国产精品成人久久小说 | 国模一区二区三区四区视频| 看黄色毛片网站| 久久国产乱子免费精品| 麻豆国产av国片精品| 亚洲成av人片在线播放无| 深夜a级毛片| 性插视频无遮挡在线免费观看| 真实男女啪啪啪动态图| 日本色播在线视频| 男人和女人高潮做爰伦理| 国产伦理片在线播放av一区 | 日本黄色片子视频| 99视频精品全部免费 在线| 哪里可以看免费的av片| 别揉我奶头 嗯啊视频| 色哟哟哟哟哟哟| 最近视频中文字幕2019在线8| 亚洲av不卡在线观看| 美女脱内裤让男人舔精品视频 | 国产综合懂色| 亚洲自拍偷在线| 成人无遮挡网站| 99精品在免费线老司机午夜| 日韩中字成人| 国产淫片久久久久久久久| 熟妇人妻久久中文字幕3abv| 亚洲国产欧洲综合997久久,| 秋霞在线观看毛片| 99视频精品全部免费 在线| 亚洲无线在线观看| 久久精品国产鲁丝片午夜精品| 国产爱豆传媒在线观看| 在线观看午夜福利视频| 看片在线看免费视频| 色噜噜av男人的天堂激情| 免费观看的影片在线观看| 久久久欧美国产精品| 久久精品国产亚洲av香蕉五月| 日韩亚洲欧美综合| 欧美激情国产日韩精品一区| АⅤ资源中文在线天堂| 国产乱人偷精品视频| 精品人妻偷拍中文字幕| 中国美女看黄片| 久久久久久久久中文| 婷婷六月久久综合丁香| 女人被狂操c到高潮| 欧美三级亚洲精品| 卡戴珊不雅视频在线播放| 午夜精品一区二区三区免费看| 久久99精品国语久久久| 久久午夜亚洲精品久久| 熟妇人妻久久中文字幕3abv| 97在线视频观看| 亚洲不卡免费看| 国产爱豆传媒在线观看| 男插女下体视频免费在线播放| 18+在线观看网站| av免费观看日本| 麻豆国产av国片精品| 国内精品一区二区在线观看| 成人特级av手机在线观看| 99热这里只有精品一区| 国产亚洲5aaaaa淫片| 欧美成人一区二区免费高清观看| 亚洲丝袜综合中文字幕| 婷婷色综合大香蕉| 日韩 亚洲 欧美在线| 黄色一级大片看看| 噜噜噜噜噜久久久久久91| 别揉我奶头 嗯啊视频| 日韩av不卡免费在线播放| 18禁在线无遮挡免费观看视频| 免费一级毛片在线播放高清视频| 少妇丰满av| 51国产日韩欧美| h日本视频在线播放| 亚洲精品国产成人久久av| 又爽又黄a免费视频| av在线观看视频网站免费| 美女cb高潮喷水在线观看| 免费看光身美女| 欧美精品国产亚洲| 乱码一卡2卡4卡精品| 深夜a级毛片| 亚洲国产色片| 日本-黄色视频高清免费观看| 亚洲av一区综合| 国产在线精品亚洲第一网站| 在线观看一区二区三区| 色视频www国产| 精品熟女少妇av免费看| 男女视频在线观看网站免费| 18+在线观看网站| 国产精品国产三级国产av玫瑰| 蜜桃亚洲精品一区二区三区| 欧美又色又爽又黄视频| 国产人妻一区二区三区在| 三级经典国产精品| av视频在线观看入口| 国产精品野战在线观看| 国产成人91sexporn| 国产日本99.免费观看| 婷婷精品国产亚洲av| or卡值多少钱| 亚洲在线观看片| 久久精品国产自在天天线| 可以在线观看的亚洲视频| 小说图片视频综合网站| 亚洲欧美日韩卡通动漫| 搞女人的毛片| 有码 亚洲区| 高清在线视频一区二区三区 | 欧美性猛交黑人性爽| 婷婷色av中文字幕| 国产三级在线视频| 熟女人妻精品中文字幕| 亚洲成人久久性| 性插视频无遮挡在线免费观看| 亚洲性久久影院| 国产成人精品婷婷| 亚洲av成人精品一区久久| 2021天堂中文幕一二区在线观| 嫩草影院入口| 午夜免费激情av| 免费大片18禁| 久久久久性生活片| 不卡视频在线观看欧美| 寂寞人妻少妇视频99o| 综合色丁香网| 亚洲国产精品国产精品| 国产高清不卡午夜福利| 精品久久久久久久久亚洲| 美女cb高潮喷水在线观看| 国产成人精品一,二区 | av国产免费在线观看| 国产高清视频在线观看网站| 久久久久九九精品影院| 观看免费一级毛片| 国产伦精品一区二区三区视频9| 国产视频内射| 男人舔奶头视频| 久久久久网色| 亚洲欧美精品自产自拍| 毛片女人毛片| 国产极品精品免费视频能看的| 亚洲国产精品成人综合色| 91精品一卡2卡3卡4卡| 亚洲av免费在线观看| 直男gayav资源| av国产免费在线观看| 青春草国产在线视频 | 国产精品久久视频播放| 大香蕉久久网| 卡戴珊不雅视频在线播放| 熟妇人妻久久中文字幕3abv| 观看美女的网站| 免费人成在线观看视频色| 日日撸夜夜添| 九九爱精品视频在线观看| 国产真实伦视频高清在线观看| 精品无人区乱码1区二区| 日本黄大片高清| 午夜免费激情av| .国产精品久久| 女人十人毛片免费观看3o分钟| 亚洲,欧美,日韩| 欧美一区二区国产精品久久精品| 啦啦啦韩国在线观看视频| 高清日韩中文字幕在线| 尤物成人国产欧美一区二区三区| 亚洲av.av天堂| 99久久人妻综合| 国产不卡一卡二| 国产精品久久久久久久久免| 精品人妻视频免费看| 久久精品夜色国产| 男女啪啪激烈高潮av片| 少妇熟女欧美另类| 免费看a级黄色片| 国产成人aa在线观看| 日本-黄色视频高清免费观看| 亚洲婷婷狠狠爱综合网| 人人妻人人澡人人爽人人夜夜 | 成人国产麻豆网| 国产单亲对白刺激| 精华霜和精华液先用哪个| 性欧美人与动物交配| av在线观看视频网站免费| 国产中年淑女户外野战色| 日韩一本色道免费dvd| 国产精华一区二区三区| 色哟哟哟哟哟哟| 99久国产av精品国产电影| 久久精品91蜜桃| 亚洲精品久久国产高清桃花| 国产老妇女一区| 一个人观看的视频www高清免费观看| 内射极品少妇av片p| 青春草亚洲视频在线观看| 国产在线男女| 国产精品爽爽va在线观看网站| 成人综合一区亚洲| 一边亲一边摸免费视频| 欧美潮喷喷水| 国国产精品蜜臀av免费| 亚洲人成网站在线观看播放| 一级二级三级毛片免费看| 日日摸夜夜添夜夜添av毛片| 日本免费a在线| 亚洲无线观看免费| 免费观看人在逋| 国产成人一区二区在线| 国产高清有码在线观看视频| 黄色一级大片看看| videossex国产| 精品不卡国产一区二区三区| 亚洲最大成人手机在线| 午夜福利高清视频| 国产日本99.免费观看| 亚洲真实伦在线观看| 午夜激情欧美在线| 中文欧美无线码| 免费看av在线观看网站| av国产免费在线观看| 老司机福利观看| 最新中文字幕久久久久| 午夜久久久久精精品| 国产精品,欧美在线| 日韩欧美国产在线观看| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 成人三级黄色视频| 特大巨黑吊av在线直播| 久久精品夜夜夜夜夜久久蜜豆| 亚洲精品乱码久久久v下载方式| 男女下面进入的视频免费午夜| 欧美高清性xxxxhd video| 久久精品久久久久久噜噜老黄 | 国产精品一区二区在线观看99 | 深夜精品福利| 国产探花在线观看一区二区| 国产视频首页在线观看| 久久精品国产亚洲av涩爱 | 身体一侧抽搐| 热99re8久久精品国产| 国产亚洲5aaaaa淫片| 性欧美人与动物交配| 亚洲精品成人久久久久久| 中文字幕免费在线视频6| 草草在线视频免费看| 日本三级黄在线观看| 国产伦精品一区二区三区视频9| 尤物成人国产欧美一区二区三区| 国产精品,欧美在线| 欧美一级a爱片免费观看看| 九色成人免费人妻av| 小蜜桃在线观看免费完整版高清| 欧美日韩乱码在线| 天天一区二区日本电影三级| 一区二区三区免费毛片| 麻豆久久精品国产亚洲av| 可以在线观看的亚洲视频| 午夜福利在线在线| 成熟少妇高潮喷水视频| 日韩制服骚丝袜av| 国产在线精品亚洲第一网站| 欧美性猛交黑人性爽| 亚洲无线观看免费| 99久久无色码亚洲精品果冻| 日本-黄色视频高清免费观看| 亚洲欧美中文字幕日韩二区| av天堂在线播放| 干丝袜人妻中文字幕| 欧美日韩精品成人综合77777| 99久久人妻综合| 黑人高潮一二区| 青春草视频在线免费观看| 亚洲精品国产成人久久av| 伦精品一区二区三区| 两个人视频免费观看高清| .国产精品久久| 亚洲最大成人手机在线| 波多野结衣高清无吗| 国产精品伦人一区二区| 99热网站在线观看| 精品国内亚洲2022精品成人| 免费大片18禁| 成人亚洲欧美一区二区av| 国产精华一区二区三区| 神马国产精品三级电影在线观看| 亚洲av不卡在线观看| 久久久久久伊人网av| 国产探花在线观看一区二区| 免费大片18禁| 麻豆乱淫一区二区| 国产精品福利在线免费观看| 别揉我奶头 嗯啊视频| av又黄又爽大尺度在线免费看 | 久久久久久久久久久免费av| 一进一出抽搐动态| av天堂在线播放| 精品日产1卡2卡| 国产精品一及| 精品久久久久久久人妻蜜臀av| 我要搜黄色片| 国产高清不卡午夜福利| 简卡轻食公司| 精品人妻视频免费看| 久久精品国产鲁丝片午夜精品| 国产男人的电影天堂91| 国产伦理片在线播放av一区 | 国内久久婷婷六月综合欲色啪| 哪个播放器可以免费观看大片| 亚洲欧美日韩高清专用| 成人性生交大片免费视频hd| 黄色日韩在线| 少妇猛男粗大的猛烈进出视频 | 九草在线视频观看| 青春草亚洲视频在线观看| 看片在线看免费视频| 波多野结衣高清作品| 最近最新中文字幕大全电影3| 色综合亚洲欧美另类图片| 特大巨黑吊av在线直播| 欧美日本亚洲视频在线播放| 国产中年淑女户外野战色| 久久久久久九九精品二区国产| 午夜免费激情av| 国产老妇女一区| 欧美xxxx黑人xx丫x性爽| 国产白丝娇喘喷水9色精品| 最近中文字幕高清免费大全6| 国产精品99久久久久久久久| 18禁在线播放成人免费| 免费av观看视频| or卡值多少钱| 欧美高清成人免费视频www| 91久久精品国产一区二区三区| 精品久久久久久久人妻蜜臀av| 色哟哟·www| 久久这里有精品视频免费| 国产精品免费一区二区三区在线| 成人欧美大片| 女人十人毛片免费观看3o分钟| 日本-黄色视频高清免费观看| 久久精品夜色国产| 热99在线观看视频| 亚洲三级黄色毛片| 国产精品女同一区二区软件| av天堂中文字幕网| 国产中年淑女户外野战色| 成人国产麻豆网| 欧美最黄视频在线播放免费| 日日干狠狠操夜夜爽| 亚洲中文字幕一区二区三区有码在线看| 青春草国产在线视频 | 中出人妻视频一区二区| 五月玫瑰六月丁香| 国产探花极品一区二区| 亚洲av免费高清在线观看| 日产精品乱码卡一卡2卡三| 直男gayav资源| 色综合站精品国产| 波野结衣二区三区在线| 午夜激情福利司机影院| 国产成人91sexporn| 久久久欧美国产精品| 亚洲婷婷狠狠爱综合网| 久久欧美精品欧美久久欧美| 99久久成人亚洲精品观看| 亚洲精品国产成人久久av| 国语自产精品视频在线第100页| 可以在线观看的亚洲视频| 国内揄拍国产精品人妻在线| 亚洲av中文字字幕乱码综合| 美女内射精品一级片tv| 久久久久久九九精品二区国产| 欧美极品一区二区三区四区| 国产精品三级大全| 大香蕉久久网| 国产黄色视频一区二区在线观看 | 欧美xxxx黑人xx丫x性爽| 此物有八面人人有两片| 别揉我奶头 嗯啊视频| 九九热线精品视视频播放| 黄色日韩在线| 99热全是精品| 亚洲一级一片aⅴ在线观看| 麻豆成人av视频| 国内精品宾馆在线| 日韩欧美精品v在线| 天堂网av新在线| 成人午夜高清在线视频| 日本免费一区二区三区高清不卡| 午夜精品国产一区二区电影 | 国产色婷婷99| 69av精品久久久久久| 中文字幕av成人在线电影| 色尼玛亚洲综合影院| 国产精品爽爽va在线观看网站| 女同久久另类99精品国产91| 国产日本99.免费观看| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 亚州av有码| 不卡视频在线观看欧美| 午夜爱爱视频在线播放| 菩萨蛮人人尽说江南好唐韦庄 | 亚洲成人av在线免费| 久久99热6这里只有精品| 久久久久久久久久黄片| 欧美+日韩+精品| 久久久久网色| 搡女人真爽免费视频火全软件| 日韩欧美在线乱码| 久久久久九九精品影院| 亚洲精品成人久久久久久| 久久这里有精品视频免费| 久久午夜福利片| 2022亚洲国产成人精品| 天堂影院成人在线观看| 欧美性感艳星| 日本-黄色视频高清免费观看| 欧美成人免费av一区二区三区| 国产精品日韩av在线免费观看| 亚洲av二区三区四区| 国产日本99.免费观看| 国产成年人精品一区二区| 大香蕉久久网| 麻豆乱淫一区二区| 亚洲18禁久久av| 伦理电影大哥的女人| 久久久久性生活片| 精品午夜福利在线看| 成年版毛片免费区| 国产视频内射| 国产av不卡久久| 免费无遮挡裸体视频| 麻豆精品久久久久久蜜桃| 日韩欧美三级三区| 少妇高潮的动态图| 欧美色欧美亚洲另类二区| 99热只有精品国产| 99久久九九国产精品国产免费| 欧美xxxx性猛交bbbb| 亚洲一级一片aⅴ在线观看| 国内精品一区二区在线观看| 精品无人区乱码1区二区| 亚洲18禁久久av| 国产白丝娇喘喷水9色精品| 桃色一区二区三区在线观看| 天堂√8在线中文| 亚洲av二区三区四区| 成人鲁丝片一二三区免费| 精品久久国产蜜桃| 熟女电影av网| 一卡2卡三卡四卡精品乱码亚洲| 我要看日韩黄色一级片| 午夜福利在线观看免费完整高清在 | 22中文网久久字幕| 国产亚洲av片在线观看秒播厂 | 国产伦精品一区二区三区视频9| 麻豆成人av视频|